ZA923747B - The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery - Google Patents
The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgeryInfo
- Publication number
- ZA923747B ZA923747B ZA923747A ZA923747A ZA923747B ZA 923747 B ZA923747 B ZA 923747B ZA 923747 A ZA923747 A ZA 923747A ZA 923747 A ZA923747 A ZA 923747A ZA 923747 B ZA923747 B ZA 923747B
- Authority
- ZA
- South Africa
- Prior art keywords
- propylxanthine
- oxohexyl
- methyl
- vascular surgery
- prophylaxis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4116799 | 1991-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA923747B true ZA923747B (en) | 1992-12-30 |
Family
ID=6432229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA923747A ZA923747B (en) | 1991-05-23 | 1992-05-22 | The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5475002A (da) |
| EP (1) | EP0514789B1 (da) |
| JP (1) | JP3193767B2 (da) |
| KR (1) | KR100219011B1 (da) |
| AT (1) | ATE142498T1 (da) |
| AU (1) | AU651205B2 (da) |
| CA (1) | CA2069202C (da) |
| DE (1) | DE59207086D1 (da) |
| DK (1) | DK0514789T3 (da) |
| ES (1) | ES2093138T3 (da) |
| GR (1) | GR3021039T3 (da) |
| HU (1) | HU207798B (da) |
| IE (1) | IE75890B1 (da) |
| IL (1) | IL101953A (da) |
| TW (1) | TW207497B (da) |
| ZA (1) | ZA923747B (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2109796C (en) * | 1991-05-24 | 2004-04-27 | James A. Bianco | Modulation of cellular response to external stimuli |
| US5981536A (en) * | 1996-07-31 | 1999-11-09 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the modulation of apoptosis |
| US5856330A (en) * | 1996-07-31 | 1999-01-05 | Hoechst Aktiengesellschaft | Use of xanthine derivatives for the inhibition of dephosphorylation of cofilin |
| WO2000071128A1 (en) * | 1999-04-06 | 2000-11-30 | Trustees Of Dartmouth College | Compositions and method for decreasing neuropathic pain |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2330742C2 (de) * | 1973-06-16 | 1982-07-29 | Hoechst Ag, 6000 Frankfurt | 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| JPH062675B2 (ja) * | 1985-04-05 | 1994-01-12 | ヘキストジヤパン株式会社 | 記憶障害治療剤 |
-
1992
- 1992-05-15 AT AT92108250T patent/ATE142498T1/de active
- 1992-05-15 EP EP92108250A patent/EP0514789B1/de not_active Expired - Lifetime
- 1992-05-15 ES ES92108250T patent/ES2093138T3/es not_active Expired - Lifetime
- 1992-05-15 DK DK92108250.9T patent/DK0514789T3/da active
- 1992-05-15 DE DE59207086T patent/DE59207086D1/de not_active Expired - Lifetime
- 1992-05-21 KR KR1019920008617A patent/KR100219011B1/ko not_active IP Right Cessation
- 1992-05-21 HU HU9201695A patent/HU207798B/hu unknown
- 1992-05-21 IL IL10195392A patent/IL101953A/en not_active IP Right Cessation
- 1992-05-22 CA CA002069202A patent/CA2069202C/en not_active Expired - Lifetime
- 1992-05-22 ZA ZA923747A patent/ZA923747B/xx unknown
- 1992-05-22 JP JP13068992A patent/JP3193767B2/ja not_active Expired - Lifetime
- 1992-05-22 AU AU17063/92A patent/AU651205B2/en not_active Expired
- 1992-07-01 IE IE921658A patent/IE75890B1/en not_active IP Right Cessation
- 1992-08-28 TW TW081106779A patent/TW207497B/zh not_active IP Right Cessation
-
1993
- 1993-11-22 US US08/155,535 patent/US5475002A/en not_active Expired - Lifetime
-
1996
- 1996-09-13 GR GR960402398T patent/GR3021039T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL101953A (en) | 1995-07-31 |
| IE75890B1 (en) | 1997-09-24 |
| KR100219011B1 (ko) | 1999-09-01 |
| IL101953A0 (en) | 1992-12-30 |
| EP0514789B1 (de) | 1996-09-11 |
| DE59207086D1 (de) | 1996-10-17 |
| JPH05139976A (ja) | 1993-06-08 |
| JP3193767B2 (ja) | 2001-07-30 |
| IE921658A1 (en) | 1992-12-02 |
| GR3021039T3 (en) | 1996-12-31 |
| DK0514789T3 (da) | 1997-02-17 |
| AU651205B2 (en) | 1994-07-14 |
| AU1706392A (en) | 1992-11-26 |
| CA2069202C (en) | 2003-12-09 |
| EP0514789A1 (de) | 1992-11-25 |
| HUT61469A (en) | 1993-01-28 |
| HU9201695D0 (en) | 1992-08-28 |
| HU207798B (en) | 1993-06-28 |
| CA2069202A1 (en) | 1992-11-24 |
| TW207497B (da) | 1993-06-11 |
| US5475002A (en) | 1995-12-12 |
| ATE142498T1 (de) | 1996-09-15 |
| ES2093138T3 (es) | 1996-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1004257A1 (en) | Use of droloxifene in the treatment of bone diseases | |
| YU209288A (en) | Process for producing compound for treating, which contains azelastin for use in nose and/or eye | |
| HU9301978D0 (en) | Application of complementary inhibitors in medical preparatives used for treatment of inflammatory diseases of intestines and skin | |
| DK0668077T3 (da) | Produkter, som indeholder G-CSF og TNF-bindende protein | |
| ZA88642B (en) | 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl)homopiperazine,various derivatives thereof,processes for the preparation of these compounds,medicaments containing them,and their use | |
| ZA923747B (en) | The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery | |
| IL97054A0 (en) | Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas | |
| GR3025518T3 (en) | Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus | |
| DE69100171D1 (de) | Synergistische kombination zur ophthalmischen verwendung. | |
| ZA888090B (en) | Agents for treating high blood pressure and cardiac insufficiency | |
| EP0355612A3 (en) | New furylthiazole derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same | |
| HU9200025D0 (en) | Medical preparations for treating depression | |
| ZA945431B (en) | Use of benzydamine in the treatment of pathological conditions caused by TNF | |
| FI950010A0 (fi) | Bradykiniiniantagonistien käyttö lääkeaineiden valmistamiseksi virussairauksien hoitamiseksi | |
| EE200100122A (et) | R-(+)-alfa-(2,3-dimetoksüfenüül)-1-[2-(4-fluorofenüül)etüül]-4-piperidiinmetanooli kasutamine unehäirete raviks | |
| GR3037039T3 (en) | Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants. | |
| ITVR930047V0 (it) | Letto per la terapia di fluidizzazione in particolare per il decupito o la cura di ustioni | |
| IT1244714B (it) | Uso della benzidamina per il trattamento della placca dentaria | |
| IT8741690A0 (it) | Farmaco per la profilassi e per la cura delle disbatteriosi vaginali. |